Kenneth J. Valenzano

Differential Regulation of the Dopamine D2and D3 Receptors by G Protein-coupled Receptor Kinases and β-Arrestins

Kyeong‐Man Kim, Kenneth J. Valenzano, Susan R. Robinson et al. · Journal of Biological Chemistry · 2001 · 304 citations · Full text

Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy

Kenneth J. Valenzano, Laykea Tafesse, Gary Lee et al. · Neuropharmacology · 2005 · 282 citations

Cannabis Use, Molecular Pharmacology, Pain Research +12

Role of Dopamine Transporter in Methamphetamine-Induced Neurotoxicity: Evidence from Mice Lacking the Transporter

Fabio Fumagalli, Raul R. Gainetdinov, Kenneth J. Valenzano et al. · Journal of Neuroscience · 1998 · 266 citations · Full text

Psychopharmacology, Methamphetamine-induced Neurotoxicity, Social Sciences +16

N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2 H)-carbox-amide (BCTC), a Novel, Orally Effective Vanilloid Receptor 1 Antagonist with Analgesic Properties: II. In Vivo Characterization in Rat Models of Inflammatory and Neuropathic Pain

James D. Pomonis, James Harrison, Lilly Mark et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 260 citations

N-(4-Tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2 H)-carbox-amide (BCTC), a Novel, Orally Effective Vanilloid Receptor 1 Antagonist with Analgesic Properties: I. In Vitro Characterization and Pharmacokinetic Properties

Kenneth J. Valenzano, Elfrida R. Grant, Gang Wu et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 249 citations · Full text